PRA Health Sciences, Inc. (the “Company”) (PRAH) today announced that KKR PRA Investors L.P. (the “Selling Stockholder”), intends to offer for sale in an underwritten secondary offering 6,666,684 shares of common stock of the Company pursuant to the Company’s shelf registration statement filed with the Securities and Exchange Commission. No shares are being sold by the Company. The last reported sale price of the Company’s common stock on September 3, 2019 was $97.59 per share.

source https://finance.yahoo.com/news/pra-health-sciences-inc-announces-212410112.html?.tsrc=rss